These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23229780)

  • 1. Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans.
    Jasion VS; Burnett BP
    Nutr J; 2015 Mar; 14():22. PubMed ID: 25880525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home-Based Treatment with Immunoglobulins: an Evaluation from the Perspective of Patients and Healthcare Professionals.
    Zuizewind CA; van Kessel P; Kramer CM; Muijs MM; Zwiers JC; Triemstra M
    J Clin Immunol; 2018 Nov; 38(8):876-885. PubMed ID: 30421274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of play and clinical prospects of antibody gene transfer.
    Hollevoet K; Declerck PJ
    J Transl Med; 2017 Jun; 15(1):131. PubMed ID: 28592330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cell distribution and immunoglobulin levels change following sciatic nerve injury in a rat model.
    Yuan W; Feng X
    Iran J Basic Med Sci; 2016 Jul; 19(7):794-9. PubMed ID: 27635205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Gammaplex(®) 5% in children and adolescents with primary immunodeficiency diseases.
    Melamed IR; Gupta S; Stratford Bobbitt M; Hyland N; Moy JN
    Clin Exp Immunol; 2016 May; 184(2):228-36. PubMed ID: 26696596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.
    Albin S; Cunningham-Rundles C
    Immunotherapy; 2014; 6(10):1113-26. PubMed ID: 25428649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and subcutaneous immunoglobulin replacement: a two-way road. Optimizing healthcare quality in patients with primary immunodeficiencies.
    Soler-Palacín P; Gasó-Gago I; Fernández-Polo A; Martín-Nalda A; Oliveras M; Martinez-Cutillas J; Figueras C
    J Clin Immunol; 2014 Nov; 34(8):1015-7. PubMed ID: 25190197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of routes of IgG administration.
    Torgerson TR
    J Clin Immunol; 2013 Jan; 33 Suppl 2():S87-9. PubMed ID: 23229780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: a multicenter study in Argentina.
    Bezrodnik L; Gómez Raccio A; Belardinelli G; Regairaz L; Díaz Ballve D; Seminario G; Moreira I; Riganti C; Cantisano C; Díaz H; Di Giovanni D
    J Clin Immunol; 2013 Oct; 33(7):1216-22. PubMed ID: 23846854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subcutaneous immunoglobulin substitution and therapy].
    Gulácsy V; Maródi L
    Orv Hetil; 2011 Jan; 152(2):64-7. PubMed ID: 21177233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous and subcutaneous immunoglobulin G replacement therapy.
    Bonilla FA
    Allergy Asthma Proc; 2016 Nov; 37(6):426-431. PubMed ID: 27931296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose.
    Berger M
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):532-8. PubMed ID: 21971330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease.
    Bonagura VR
    J Clin Immunol; 2013 Jan; 33 Suppl 2():S90-4. PubMed ID: 23271459
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.